Donepezil reverses nicotine withdrawal-induced deficits in contextual fear conditioning in C57BL/6J mice

Behavioral Neuroscience

Volumn 128, Issue 5, 2014, Pages 588-593

  Poole, Rachel L ^a   Connor, David A ^a   Gould, Thomas J ^a  

^a TEMPLE UNIVERSITY   (United States)

Author keywords

Acetylcholinesterase; Addiction; Cognition; Learning; Withdrawal

Indexed keywords

DONEPEZIL; CHOLINESTERASE INHIBITOR; INDAN DERIVATIVE; NICOTINE; NICOTINIC AGENT; NOOTROPIC AGENT; PIPERIDINE DERIVATIVE;

ACUTE DRUG ADMINISTRATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANXIETY; ARTICLE; ASSOCIATION; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; DRUG EXPOSURE; FEAR; HIPPOCAMPUS; LEARNING DISORDER; LOCOMOTION; LOW DRUG DOSE; MALE; MOUSE; NONHUMAN; OPEN FIELD TEST; SMOKING CESSATION; ANIMAL; C57BL MOUSE; CATALEPSY; CONDITIONING; DRUG EFFECTS; ELECTRIC SHOCK; PSYCHOLOGY; SUBSTANCE WITHDRAWAL SYNDROME;

ANIMALS; CHOLINESTERASE INHIBITORS; CONDITIONING (PSYCHOLOGY); ELECTROSHOCK; FEAR; FREEZING REACTION, CATALEPTIC; INDANS; LOCOMOTION; MALE; MICE, INBRED C57BL; NICOTINE; NICOTINIC AGONISTS; NOOTROPIC AGENTS; PIPERIDINES; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 84925754673     PISSN: 07357044     EISSN: 19390084     Source Type: Journal    
DOI: 10.1037/bne0000003     Document Type: Article

References (51)

1. André, J. M., Gulick, D., Portugal, G. S., & Gould, T. J. (2008). Nicotine withdrawal disrupts both foreground and background contextual fear conditioning but not pre-pulse inhibition of the acoustic startle response in C57BL/6 mice. Behavioural Brain Research, 190, 174-181. doi: 10.1016/j.bbr.2008.02.018
2. Ashare, R. L., Falcone, M., & Lerman, C. (2014). Cognitive function during nicotine withdrawal: Implications for nicotine dependence treatment. Neuropharmacology, 76, 581-591. doi:10.1016/j.neuropharm .2013.04.034
3. Ashare, R. L., Ray, R., Lerman, C., & Strasser, A. A. (2012). Cognitive effects of the acetylcholinesterase inhibitor, donepezil, in healthy, non-treatment seeking smokers: A pilot feasibility study. Drug and Alcohol Dependence, 126, 263-267. doi:10.1016/j.drugalcdep.2012 .04.019
4. Bell, S. L., Taylor, R. C., Singleton, E. G., Henningfield, J. E., & Heishman, S. J. (1999). Smoking after nicotine deprivation enhances cognitive performance and decreases tobacco craving in drug abusers. Nicotine & Tobacco Research, 1, 45-52. doi:10.1080/14622299050011141
5. Besson, M., Granon, S., Mameli-Engvall, M., Cloëz-Tayarani, I., Maubourguet, N., Cormier, A. Faure., P. (2007). Long-term effects of chronic nicotine exposure on brain nicotinic receptors. Proceedings of the National Academy of Sciences of the United States of America, 104, 8155-8160. doi:10.1073/pnas.0702698104
6. Blake, J., & Smith, A. (1997). Effects of smoking and smoking deprivation on the articulatory loop of working memory. Human Psychopharmacology: Clinical and Experimental, 12, 259 -264. doi: 10.1002/(SICI)1099-1077(199705/06)12:3<259::AID-HUP866>3.0 .CO;2-F
7. Blanchard, R. J., & Blanchard, D. C. (1969). Passive and active reactions to fear-eliciting stimuli. Journal of Comparative and Physiological Psychology, 68, 129-135. doi:10.1037/h0027676
8. Cahill, K., Stead, L. F., & Lancaster, T. (2012). Nicotine receptor partial agonists for smoking cessation. Cochrane Database of Systematic Reviews, 4, CD006103. doi:10.1002/14651858.CD006103.pub6
9. Cosgrove, K. P., Batis, J., Bois, F., Maciejewski, P. K., Esterlis, I., Kloczynski, T.,. Staley, J. K. (2009). 2-nicotinic acetylcholine receptor availability during acute and prolonged abstinence from tobacco smoking. Archives of General Psychiatry, 66, 666-676. doi: 10.1001/archgenpsychiatry.2009.41
10. Csernansky, J. G., Martin, M., Shah, R., Bertchume, A., Colvin, J., & Dong, H. (2005). Cholinesterase inhibitors ameliorate behavioral deficits induced by MK-801 in mice. Neuropsychopharmacology, 30, 2135-2143. doi:10.1038/sj.npp.1300761
11. Czerniawski, J., Ree, F., Chia, C., & Otto, T. (2012). Dorsal versus ventral hippocampal contributions to trace and contextual conditioning: Differential effects of regionally selective NMDA receptor antagonism on acquisition and expression. Hippocampus, 22, 1528-1539. doi:10.1002/ hipo.20992
12. Davis, J. A., & Gould, T. J. (2007). Atomoxetine reverses nicotine withdrawal-associated deficits in contextual fear conditioning. Neuropsychopharmacology, 32, 2011-2019. doi:10.1038/sj.npp.1301315
13. Davis, J. A., James, J. R., Siegel, S. J., & Gould, T. J. (2005). Withdrawal from chronic nicotine administration impairs contextual fear conditioning in C57BL/6 mice. The Journal of Neuroscience, 25, 8708-8713. doi:10.1523/JNEUROSCI.2853-05.2005
14. Easton, A., Sankaranarayanan, S., Tanghe, A., Terwel, D., Lin, A. X., Hoque, N.,. Bristow, L. (2013). Effects of sub-chronic donepezil on brain Abeta and cognition in a mouse model of Alzheimer's disease. Psychopharmacology, 230, 279-289. doi:10.1007/s00213-013-3152-3
15. Geerts, H., Guillaumat, P. O., Grantham, C., Bode, W., Anciaux, K., & Sachak, S. (2005). Brain levels and acetylcholinesterase inhibition with galantamine and donepezil in rats, mice, and rabbits. Brain Research, 1033, 186-193. doi:10.1016/j.brainres.2004.11.042
16. Gould, T. J. (2006). Nicotine and hippocampus-dependent learning. Molecular Neurobiology, 34, 93-107. doi:10.1385/MN:34:2:93
17. Gould, T. J., Portugal, G. S., André, J. M., Tadman, M. P., Marks, M. J., Kenney, J. W.,. Adoff, M. (2012). The duration of nicotine withdrawal-associated deficits in contextual fear conditioning parallels changes in hippocampal high affinity nicotinic acetylcholine receptor upregulation. Neuropharmacology, 62, 2118 -2125. doi:10.1016/j .neuropharm.2012.01.003
18. Hatip-Al-Khatib, I., Takashi, A., Egashira, N., Iwasaki, K., & Fujiwara, M. (2004). Comparison of the effect of TAK-147 (zanapezil) and E-2020 (donepezil) on extracellular acetylcholine level and blood flow in the ventral hippocampus of freely moving rats. Brain Research, 1012, 169-176. doi:10.1016/j.brainres.2004.03.067
19. Herrmann, N., Chau, S. A., Kircanski, I., & Lanctôt, K. L. (2011). Current and emerging drug treatment options for Alzheimer's disease, Drugs, 71, 2031-2065. doi:10.2165/11595870-000000000-00000
20. Hughes, J. R. (2007). Effects of abstinence from tobacco: Valid symptoms and time course. Nicotine & Tobacco Research, 9, 315-327. doi:10.1080/ 14622200701188919
21. Hughes, J. R., & Keenan, R. M. (1989). Effect of tobacco withdrawal on sustained attention, Addictive Behaviors, 14, 577-580. doi:10.1016/ 0306-4603(89)90079-8
22. Ihalainen, J., Sarajärvi, T., Rasmusson, D., Kemppainen, S., Keski-Rahkonen, P., Lehtonen, M.,. Tanila, H. (2011). Effects of memantine and donepezil on cortical and hippocampal acetylcholine levels and object recognition memory in rats. Neuropharmacology, 61, 891-899. doi:10.1016/j.neuropharm.2011.06.008
23. Jacobsen, L. K., Krystal, J. H., Mencl, W. E., Westerveld, M., Frost, S. J., & Pugh, K. R. (2005). Effects of smoking and smoking abstinence on cognition in adolescent tobacco smokers. Biological Psychiatry, 57, 56-66. doi:10.1016/j.biopsych.2004.10.022
24. Kenney, J. W., Adoff, M. D., Wilkinson, D. S., & Gould, T. J. (2011). The effects of acute, chronic, and withdrawal from chronic nicotine on novel and spatial object recognition in male C57BL/6J mice. Psychopharmacology, 217, 353-365. doi:10.1007/s00213-011-2283-7
25. Kimmey, B. A., Rupprecht, L. E., Hayes, M. R., & Schmidt, H. D. (2012). Donepezil, an acetylcholinesterase inhibitor, attenuates nicotine selfadministration and reinstatement of nicotine seeking in rats. Addiction Biology. Advance online publication. doi:10.1111/adb.12014
26. Lanctôt, K. L., Herrmann, N., Yau, K. K., Khan, L. R., Liu, B. A., LouLou, M. M., & Einarson, T. R. (2003). Efficacy and safety of cholinesterase inhibitors in Alzheimer's disease: A meta-analysis. CMAJ: Canadian Medical Association Journal, 169(6), 557-564.
27. Lipkind, D., Sakov, A., Kafkafi, N., Elmer, G. I., Benjamini, Y., & Golani, I. (2004). New replicable anxiety-related measures of wall vs. center behavior of mice in the open field. Journal of Applied Physiology, 97, 347-359. doi:10.1152/japplphysiol.00148.2004
28. Mamede, M., Ishizu, K., Ueda, M., Mukai, T., Iida, Y., Kawashima, H.,. Saji, H. (2007). Temporal change in human nicotinic acetylcholine receptor after smoking cessation: 5IA SPECT study. Journal of Nuclear Medicine, 48, 1829-1835. doi:10.2967/jnumed.107.043471
29. Markou, A. (2008). Neurobiology of nicotine dependence. Philosophical Transactions of the Royal Society of London, 363, 3159-3168. doi: 10.1098/rstb.2008.0095
30. Marks, M. J., Burch, J. B., & Collins, A. C. (1983). Effects of chronic nicotine infusion on tolerance and nicotinic receptors. Journal of Pharmacology and Experimental Therapeutics, 226(3), 817-825.
31. McIlwain, K. L., Merriweather, M. Y., Yuva-Paylor, L. A., & Paylor, R. (2001). The use of behavioral test batteries: Effects of training history. Physiology & Behavior, 73, 705-717. doi:10.1016/S0031-9384(01)00528-5
32. Nides, M. (2008). Update on pharmacologic options for smoking cessation treatment. The American Journal of Medicine, 121(4 Supp. 1), S20-S31. doi:10.1016/j.amjmed.2008.01.016
33. Patterson, F., Jepson, C., Loughead, J., Perkins, K., Strasser, A. A., Siegel, S. Lerman, C. (2010). Working memory deficits predict short-term smoking resumption following brief abstinence. Drug and Alcohol Dependence, 106, 61-64. doi:10.1016/j.drugalcdep.2009.07.020
34. Phillips, R. G., & LeDoux, J. E. (1992). Differential contribution of amygdala and hippocampus to cued and contextual fear conditioning. Behavioral Neuroscience, 106, 274-285. doi:10.1037/0735-7044.106.2 .274
35. Picciotto, M. R., Addy, N. A., Mineur, Y. S., & Brunzell, D. H. (2008). It is not "either/or": Activation and desensitization of nicotinic acetylcholine receptors both contribute to behaviors related to nicotine addiction and mood. Progress in Neurobiology, 84, 329 -342. doi:10.1016/j .pneurobio.2007.12.005
36. Portugal, G. S., & Gould, T. J. (2007). Bupropion dose-dependently reverses nicotine withdrawal deficits in contextual fear conditioning. Pharmacology, Biochemistry and Behavior, 88, 179-187. doi:10.1016/j .pbb.2007.08.004
37. Portugal, G. S., & Gould, T. J. (2009). Nicotine withdrawal disrupts new contextual learning. Pharmacology, Biochemistry and Behavior, 92, 117-123. doi:10.1016/j.pbb.2008.11.001
38. Raybuck, J. D., & Gould, T. J. (2009). Nicotine withdrawal-induced deficits in trace fear conditioning in C57BL/6 mice-a role for highaffinity beta2 subunit-containing nicotinic acetylcholine receptors. European Journal of Neuroscience, 29, 377-387. doi:10.1111/j.1460-9568 .2008.06580.x
39. Raybuck, J. D., Portugal, G. S., Lerman, C., & Gould, T. J. (2008). Varenicline ameliorates nicotine withdrawal-induced learning deficits in C57BL/6 mice. Behavioral Neuroscience, 122, 1166-1171. doi:10.1037/a0012601
40. Rukstalis, M., Jepson, C., Patterson, F., & Lerman, C. (2005). Increases in hyperactive-impulse symptoms predict relapse among smokers in nicotine replacement therapy. Journal of Substance Abuse Treatment, 28, 297-304. doi:10.1016/j.jsat.2005.02.002
41. Schwartz, R. D., & Kellar, K. J. (1985). In vivo regulation of [3H] acetylcholine recognition sites in brain by nicotinic cholinergic drugs. Journal of Neurochemistry, 45, 427-433. doi:10.1111/j.1471-4159.1985 .tb04005.x
42. Shigeta, M., & Homma, A. (2001). Donepezil for Alzheimer's disease: Pharmacodynamic, pharmacokinetic, and clinical profiles, CNS Drug Reviews, 7, 353-368. doi:10.1111/j.1527-3458.2001.tb00204.x
43. Staley, J. K., Krishnan-Sarin, S., Cosgrove, K. P., Krantzler, E., Frohlich, E., Perry, E.,. van Dyck, C. H. (2006). Human tobacco smokers in early abstinence have higher levels of beta2* nicotinic acetylcholine receptors than nonsmokers. The Journal of Neuroscience, 26, 8707-8714. doi:10.1523/JNEUROSCI.0546-06.2006
44. Tota, S., Goel, R., Pachauri, S. D., Rajasekar, N., Najmi, A. K., Hanif, K., & Nath, C. (2013). Effect of angiotensin II on spatial memory, cerebral blood flow, cholinergic neurotransmission, and brain derived neurotrophic factor in rats. Psychopharmacology, 226, 357-369. doi: 10.1007/s00213-012-2913-8
45. Turner, J. R., Gold, A., Schnoll, R., & Blendy, J. A. (2013). Translational research in nicotine dependence. Cold Spring Harbor Perspectives in Medicine, 3, a012153. doi:10.1101/cshperspect.a012153
46. U.S. Department of Health and Human Services. (1988). The health consequences of smoking: Nicotine addiction. A report of the Surgeon General. Washington, DC: U.S. Department of Health and Human Services, Public Health Service, Centers for Disease Control, Disease Prevention and Health Promotion, Office on Smoking and Health: Washington, DC.
47. U.S. Department of Health and Human Services. (2014). The health consequences of smoking-50 years of progress: A report of the Surgeon General. Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office of Smoking and Health.
48. Wilkinson, D. S., & Gould, T. J. (2011). The effects of galantamine on nicotine withdrawal-induced deficits in contextual fear conditioning in C57BL/6 mice. Behavioural Brain Research, 223, 53-57. doi:10.1016/j .bbr.2011.04.010
49. Wilkinson, D. S., & Gould, T. J. (2013). Withdrawal from chronic nicotine and subsequent sensitivity to nicotine challenge on contextual learning. Behavioural Brain Research, 250, 58-61. doi:10.1016/j.bbr.2013.04 .053
50. Wilkinson, D. S., Turner, J. R., Blendy, J. A., & Gould, T. J. (2013). Genetic background influences the effects of withdrawal from chronic nicotine on learning and high-affinity nicotinic acetylcholine receptor binding in the dorsal and ventral hippocampus. Psychopharmacology, 225, 201-208. doi:10.1007/s00213-012-2808-8
51. Zurkovsky, L., Bychkov, E., Tsakem, E. L., Siedlecki, C., Blakely, R. D., & Gurevich, E. V. (2013). Cognitive effects of dopamine depletion in the context of diminished acetylcholine signaling capacity in mice. Disease Models & Mechanisms, 6, 171-183. doi:10.1242/dmm.010363